Acute blood pressure effects of YC-1-induced activation of soluble guanylyl cyclase in normotensive and hypertensive rats

British Journal of Pharmacology

Volumn 130, Issue 2, 2000, Pages 205-208

  Rothermund, Lars ^a   Friebe, Andreas ^a   Paul, Martin ^a   Koesling, Doris ^a   Kreutz, Reinhold ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Blood pressure; Cyclic GMP; Hypertension; L NAME; Nitric oxide; Soluble guanylyl cyclase; YC 1

Indexed keywords

1 BENZYL 3 (5 HYDROXYMETHYL 2 FURYL)INDAZOLE; CYCLIC GMP; DRUG VEHICLE; GUANYLATE CYCLASE; N(G) NITROARGININE METHYL ESTER; NITROPRUSSIDE SODIUM; PENTOBARBITAL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT;

EID: 0034114153     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703320     Document Type: Article

References (14)

1. BROOKER, G., HARPER, J.F., TERASAKI, W.L. & MOYLAN, R.D. (1979). Radioimmunoassay of cyclic AMP and cyclic GMP. Adv. Cyclic. Nucleotide. Res., 10, 1-33.
2. BRUNE, B., SCHMIDT, K.U. & ULLRICH, V. (1990). Activation of soluble guanylate cyclase by carbon monoxide and inhibition by superoxide anion. Eur. J. Biochem., 192, 683-688.
3. FRIEBE, A. & KOESLING, D. (1998). Mechanism of YC-1-induced activation of soluble guanylyl cyclase. Mol. Pharmacol., 53, 123-127.
4. FRIEBE, A., MÜLLERSHAUSEN, F., SMOLENSKI, A., WALTER, U., SCHULTZ, G. & KOESLING, D. (1998). YC-1 potentiates nitric oxide-and carbon monoxide-induced cyclic GMP effects in human platelets. Mol. Pharmacol., 54, 962-967.
5. FRIEBE, A., SCHULTZ, G. & KOESLING, D. (1996). Sensitizing soluble guanylyl cyclase to become a highly CO-sensitive enzyme. EMBO J., 15, 6863-6868.
6. GALLE, J., ZABEL, U., HUBNER, U., HATZELMANN, A., WAGNER, B., WANNER, C. & SCHMIDT, H.H. (1999). Effects of the soluble guanylyl cyclase activator, YC-1, on vascular tone, cyclic GMP levels and phosphodiesterase activity. Br. J. Pharmacol., 127, 195-203.
7. GERZER, R., HAMET, P., ROSS, A.H., LAWSON, J.A. & HARDMAN, J.G. (1983). Calcium-induced release from platelet membranes of fatty acids that modulate soluble guanylate cyclase. J. Pharmacol. Exp. Ther., 226, 180-186.
8. GRAFF, G., STEPHENSON, J.H., GLASS, D.B., HADDOX, M.K. & GOLDBERG, N.D. (1978). Activation of soluble splenic cell guanylate cyclase by prostaglandin endoperoxides and fatty acid hydroperoxides. J. Biol. Chem., 253, 7662-7676.
9. IGNARRO, L.J., WOOD, K.S. & WOLIN, M.S. (1982). Activation of purified soluble guanylate cyclase by protoporphyrin IX. Proc. Natl. Acad. Sci. U.S.A., 79, 2870-2873.
10. KO, F.N., WU, C.C., KUO, S.C., LEE, F.Y. & TENG, C.M. (1994). YC-1, a novel activator of platelet guanylate cyclase. Blood, 84, 4226-4233.
11. MONCADA, S., REES, D.D., SCHULZ, R. & PALMER, R.M. (1991). Development and mechanism of a specific supersensitivity to nitrovasodilators after inhibition of vascular nitric oxide synthesis in vivo. Proc. Natl. Acad. Sci. U.S.A., 88, 2166-2170.
12. MÜLSCH, A., BAUERSACHS, J., SCHAFER, A., STASCH, J.P., KAST, R. & BUSSE, R. (1997). Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators. Br. J. Pharmacol., 120, 681-689.
13. RUBANYI, G.M., ROMERO, J.C. & VANHOUTTE, P.M. (1986). Flow-induced release of endothelium-derived relaxing factor. Am. J. Physiol., 250, H1145-H1149.
14. TENG, C.M., WU, C.C., KO, F.N., LEE, F.Y. & KUO, S.C. (1997). YC-1, a nitric oxide-independent activator of soluble guanylate cyclase, inhibits platelet-rich thrombosis in mice. Eur. J. Pharmacol., 320, 161-166.